D. Niethammer

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

Alfred Reiter, Martin Schrappe, WD Ludwig et al. · Blood · 1994 · 614 citations · Full text

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann et al. · Blood · 2008 · 601 citations · Full text

Determinants of Antileukemia Effects of Allogeneic NK Cells

Wing Leung, Rekha Iyengar, Victoria Turner et al. · The Journal of Immunology · 2004 · 420 citations

Hematological Malignancy, Cell Therapy, Transplantation +15

Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children

Rupert Handgretinger, Thomas Klingebiel, Peter Lang et al. · Bone Marrow Transplantation · 2001 · 279 citations

Histocompatibility, Transplantation, Megadose Transplantation +12

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group

G. Henze, R. Fengler, R. Hartmann et al. · Blood · 1991 · 265 citations · Full text